Literature DB >> 6686406

Reaction of the substantia nigra to massive basal ganglia infarction.

L S Forno.   

Abstract

The human substantia nigra can react to destruction of the basal ganglia in several ways. In ten brains with massive unilateral infarction of the basal ganglia slight to moderate nerve cell loss was present in the ipsilateral substantia nigra. The severe nerve cell loss reported in mostly young experimental animals was not observed. One case also displayed a fine network of myelinated and unmyelinated fibers surrounding pigmented nerve cells and dendrites in the ispilateral substantia nigra. Electron microscopy of the substantia nigra from this case showed neurofilamentous hyperplasia, paired helical filaments and rare straight filaments, but only on the side ipsilateral to the striatal infarct. The nerve cell loss in the ten cases was interpreted as a mainly retrograde degeneration, the perineuronal sprouts in case 10 as a reaction to partial deafferentation, and the paired helical filaments as either a retrograde or a transsynaptic reaction in the substantia nigra ipsilateral to the basal ganglia destruction.

Entities:  

Mesh:

Year:  1983        PMID: 6686406     DOI: 10.1007/bf00684925

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Ultrastructure of axonal reaction in red nucleus of cat.

Authors:  K D Barron; M P Dentinger; L R Nelson; J E Mincy
Journal:  J Neuropathol Exp Neurol       Date:  1975-05       Impact factor: 3.685

2.  Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods.

Authors:  D J Reis; G Gilad; V M Pickel; T H Joh
Journal:  Brain Res       Date:  1978-04-14       Impact factor: 3.252

Review 3.  Regeneration of monoaminergic and cholinergic neurons in the mammalian central nervous system.

Authors:  A Björklund; U Stenevi
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

4.  Neurofilamentous hyperplasia in inferior olivary hypertrophy.

Authors:  D S Horoupian; H Wiśniewski
Journal:  J Neuropathol Exp Neurol       Date:  1971-10       Impact factor: 3.685

5.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

6.  Crossed cerebellar atrophy: an old problem revisited.

Authors:  A M Strefling; H Urich
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

7.  Fine structure of neurons of the hypertrophied human inferior olive.

Authors:  K D Barron; M P Dentinger; A H Koeppen
Journal:  J Neuropathol Exp Neurol       Date:  1982-03       Impact factor: 3.685

8.  Nigrostriatal and nigrothalamic fibers in the rhesus monkey.

Authors:  M B Carpenter; P Peter
Journal:  J Comp Neurol       Date:  1972-01       Impact factor: 3.215

9.  Nigrofugal connections in the primate brain.

Authors:  F A Mettler
Journal:  J Comp Neurol       Date:  1970-03       Impact factor: 3.215

10.  The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey.

Authors:  P Bédard; L Larochelle; A Parent; L J Poirier
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

View more
  23 in total

1.  The L-dopa response in vascular parkinsonism.

Authors:  J C M Zijlmans; R Katzenschlager; S E Daniel; A J L Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

2.  Selective loss of nigral neurons in Pick's disease: a morphometric study.

Authors:  T Uchihara; K Tsuchiya; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Reversible movement disorder in a patient with post traumatic basal ganglia haematoma.

Authors:  A Pauranik; A Verma; M C Maheshwari
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

4.  Abnormal arborizations of Purkinje cell dendrites in Creutzfeldt-Jakob disease: a manifestation of neuronal plasticity?

Authors:  J K Tiller-Borcich; H Urich
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

5.  Magnetic resonance imaging of local and remote vascular remodelling after experimental stroke.

Authors:  Pavel Yanev; Peter R Seevinck; Umesh S Rudrapatna; Mark Jrj Bouts; Annette van der Toorn; Karen Gertz; Golo Kronenberg; Matthias Endres; Geralda A van Tilborg; Rick M Dijkhuizen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Astrocytic swelling in the ipsilateral substantia nigra after occlusion of the middle cerebral artery in rats.

Authors:  M Nakane; A Tamura; N Miyasaka; T Nagaoka; T Kuroiwa
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

Review 7.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

8.  Transneuronal degeneration in patients with temporal lobe epilepsy: evaluation by MR imaging.

Authors:  Fumiko Kodama; Toshihide Ogawa; Shuji Sugihara; Masayuki Kamba; Norimasa Kohaya; Shinji Kondo; Toshibumi Kinoshita
Journal:  Eur Radiol       Date:  2003-04-18       Impact factor: 5.315

Review 9.  Customized Brain Cells for Stroke Patients Using Pluripotent Stem Cells.

Authors:  Zaal Kokaia; Irene L Llorente; S Thomas Carmichael
Journal:  Stroke       Date:  2018-04-18       Impact factor: 7.914

10.  A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease.

Authors:  M Tabaton; A Schenone; P Romagnoli; G L Mancardi
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.